FindTrial
Sign In

A PHARMACOKINETIC PHASE I STUDY TO ASSESS THE COMPARATIVE BIOAVAILABILITY OF 17-B-ESTRADIOL FROM A METERED DOSE TRANSDERMAL SYSTEM (MDTS) AND ESTRADERM 50 PATCHES IN HEALTHY POSTMENOPAUSAL WOMEN, AS HORMONE REPLACEMENT THERAPY

A PHARMACOKINETIC PHASE I STUDY TO ASSESS THE COMPARATIVE BIOAVAILABILITY OF 17-B-ESTRADIOL FROM A METERED DOSE TRANSDERMAL SYSTEM (MDTS) AND ESTRADERM 50 PATCHES IN HEALTHY POSTMENOPAUSAL WOMEN, AS HORMONE REPLACEMENT THERAPY

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000591651
Enrollment
26
Registered
2005-10-05
Start date
2001-02-08
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

ESTRADIOL METERED DOSE TRANSDERMAL SYSTEM (MDTS) AND ESTRADERM 50 PATCHES FOR 6 DAYS.

Sponsors

FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Healthy postmenopausal women

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026